Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Clinical trial NCT03969121 · COMPLETED

Trial details

NCT number: NCT03969121
Sponsor: Kyoto Breast Cancer Research Network
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Female Hormone Receptor Positive Malignant Neoplasm of Breast

Start date: 2019-07-16
Primary completion: 2021-12-23
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.